President Trump recently unveiled his latest initiative to standardize drug pricing, tying government drug payments to lower prices abroad. Trump also signaled his intent to eliminate pharmaceutical industry middlemen — pharmacy-benefit managers — who are “ripping off Medicare patients with high prescription prices,” he said. The policies, the president claimed, are the “the biggest ever…